Analysis of the spontaneous scratching behavior by NC/Nga mice: a possible approach to evaluate antipruritics for subjects with atopic dermatitis

被引:68
作者
Takano, N [1 ]
Arai, I [1 ]
Kurachi, M [1 ]
机构
[1] Taisho Pharmaceut Co Ltd, Dept Pharmacol Evaluat Lab, Self Medicat Lab, Kita Ku, Saitama 3319530, Japan
关键词
atopic dermatitis; NC/Nga; mouse; scratching; itch; MicroAct;
D O I
10.1016/S0014-2999(03)01828-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the spontaneous scratching by NC/Nga mice to design a new method for evaluating the itch of subjects with atopic dermatitis. The numbers of scratchings in various strains of mice were classified based on the duration of the scratching. Prolonged scratching was frequent in skin-lesioned NC/Nga mice, but not in ICR, BALB/c and non-lesioned NC/Nga mice. Pretreatment with dexamethasone or tacrolimus significantly suppressed long-duration scratching in NC/Nga mice but did not suppress short-duration scratching induced by ovalbumin active cutaneous anaphylaxis in BALB/c mice and in ICR mice subcutaneously injected with histamine. In contrast, pretreatment with chlorpheniramine or ketotifen significantly suppressed short-duration scratching induced by ovalbumin active cutaneous anaphylaxis in BALB/c mice and in ICR mice subcutaneously injected with histamine, but not long-duration scratching seen in NC/Nga mice. These findings indicate that the mechanism of spontaneous scratching in NC/Nga mice differs from that induced by several pruritogen injections. This new method shows good correlation with the therapeutic activity of drugs in cases of atopic dermatitis in humans and may serve as a useful model for evaluating antipruritic drugs and for studying mechanisms involved in atopic dermatitis. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 31 条
[1]  
ANDERSSON J, 1992, IMMUNOLOGY, V75, P136
[2]  
Andoh T, 1998, J PHARMACOL EXP THER, V286, P1140
[3]  
[Anonymous], ACTA DERM VENERE S92, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]
[4]  
Assmann T, 2001, Expert Opin Pharmacother, V2, P1167
[5]   FAILURE OF TERFENADINE IN RELIEVING THE PRURITUS OF ATOPIC-DERMATITIS [J].
BERTHJONES, J ;
GRAHAMBROWN, RAC .
BRITISH JOURNAL OF DERMATOLOGY, 1989, 121 (05) :635-637
[6]   Pathophysiology of itching [J].
Greaves, MW ;
Wall, PD .
LANCET, 1996, 348 (9032) :938-940
[7]  
HAGERMARK O, 1992, SKIN PHARMACOL, V5, P1
[8]  
HAGERMARK O, 1996, DERMATOL THER, V1, P75
[9]   Update on therapy of atopic dermatitis [J].
Hanifin, JM ;
Tofte, SJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (03) :S123-S125
[10]  
Hiroi Jun, 2001, Folia Pharmacologica Japonica, V117, P351, DOI 10.1254/fpj.117.351